AC Immune SA (ACIU)

AC Immune Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	57.01	78.49	31.59	82.22	160.89	193.59
Short-Term Investments	47.81	24.55	91	116	65	95
Cash & Cash Equivalents	104.82	103.05	122.59	198.22	225.89	288.59
Cash Growth	-0.58%	-15.94%	-38.16%	-12.25%	-21.72%	54.77%
Receivables	0.87	15.42	0.39	0.43	0.33	0.3
Other Current Assets	4.18	6.68	5.12	3.99	5.55	3.88
Total Current Assets	109.87	125.15	128.09	202.63	231.77	292.77
Property, Plant & Equipment	6.58	6.88	7.07	8.03	6.64	6.17
Long-Term Investments	0.42	0.36	0.36	0.36	0.33	0.3
Goodwill and Intangibles	50.42	50.42	50.42	50.42	0	0
Total Long-Term Assets	57.41	57.66	57.84	58.81	6.97	6.48
Total Assets	167.28	182.81	185.94	261.44	238.74	299.25
Accounts Payable	2.84	1.68	0.93	2	2.18	0.14
Deferred Revenue	0.07	0.14	0.59	0.72	0.31	4.48
Current Debt	0.67	0.67	0.55	0.57	0.44	1.09
Other Current Liabilities	10.54	11.09	9.42	16.74	11.09	11.8
Total Current Liabilities	14.12	13.58	11.48	20.03	14.02	17.51
Long-Term Debt	2.66	2.83	2.25	2.34	1.78	1.81
Other Long-Term Liabilities	5.82	5.77	3.21	7.1	7.46	7.49
Total Long-Term Liabilities	8.48	8.6	5.47	9.44	9.24	9.3
Total Liabilities	22.6	22.17	16.95	29.46	23.26	26.81
Total Debt	3.33	3.5	2.8	2.91	2.22	2.91
Debt Growth	24.87%	24.85%	-3.75%	30.90%	-23.53%	461.20%
Retained Earnings	-332.56	-316.2	-264.02	-200.94	-132.85	-75.52
Comprehensive Income	-0.04	-0.05	0.01	0	0	0
Shareholders' Equity	144.68	160.64	168.99	231.98	215.48	272.44
Net Cash / Debt	101.49	99.55	119.79	195.31	223.67	285.68
Net Cash / Debt Growth	-1.24%	-16.89%	-38.67%	-12.68%	-21.71%	53.64%
Working Capital	95.75	111.58	116.61	182.61	217.75	275.26
Book Value Per Share	1.46	1.90	2.00	3.18	3.00	4.03

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).